← SynDRA
O-CHLOROACETYLCARBAMOYLFUMAGILLOL
SynDRA canonical compound SYN0004699 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | METAP2 |
| Mechanism of action | Methionine aminopeptidase inhibitor |
All known targets
Mechanisms of action (all sources)
- Cell cycle inhibitor
- Methionine aminopeptidase inhibitor
- METAP2 INHIBITOR
Drug classes
- Angiogenesis Inhibitors
- Antibiotics, Antineoplastic
Cross-references
Synonyms
- Tnp-470
- AGM-1470
- NSC-642492
- tnp 470
- CCRIS 8049
- C19H28ClNO6
- O-chloroacetylcarbamoyl fumagillol
- MSHZHSPISPJWHW-HUTWWKRSSA-N
- Carbamic acid, (chloroacetyl)-, 5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)oct-6-yl ester, (3R-(3alpha,4alpha(2R*,3R*),5beta,6beta))-
- TNP-470
- O-(chloroacetylcarbamoyl)fumagillol
- NSC642492
- DRG-0148
- Lodamin
- NSC 642492
- X47GR46481
- CHEBI:90748
- DTXCID00819891
- RefChem:898528
- mPEG-PLA-TNP-470
- TNP470
- AGM1470
- UNII-X47GR46481
- orb1706526
- SCHEMBL1652694
- BDBM17446
- MSHZHSPISPJWHW-PVDLLORBSA-N
- TNP-470 [MI]
- GLXC-06754
- EFA29891
- Tox21_303433
- EX-A11072
- AKOS040742752
- CCG-208103
- CS-8106
- NCGC00257293-01
- DA-68246
- MS-26845
Look up O-CHLOROACETYLCARBAMOYLFUMAGILLOL in the interactive SynDRA portal →